FDA Enforcement Database

Drug Safety & Recalls Center

Access structured drug recall and safety information sourced directly from the U.S. Food & Drug Administration (FDA) OpenFDA Enforcement API. Stay informed on active market withdrawals, manufacturing defect notices, and drug safety advisories.

Last Synchronized
2 weeks ago
Total FDA Recalls
999
Active / Ongoing
962
Critical (Class I)
45
Data Provenance & Source Transparency: All drug recall records displayed are retrieved directly from the official U.S. FDA OpenFDA Enforcement API. Questo organizes and presents this data for medical education and research without modifying original regulatory facts. Explore OpenFDA API Documentation →
Medical & Legal Disclaimer: The information on this page is compiled for informational and educational reference only and does not constitute medical advice or clinical diagnosis. Never discontinue, start, or substitute any medication without consulting your prescribing doctor or a licensed pharmacist. For urgent health concerns regarding a recalled product, contact your physician immediately or report adverse events to FDA MedWatch.
Showing 701–720 of 999 factual FDA recall reports
Class II (Moderate Risk)
Drug recall Recall #: D-0002-2026

ENTECAVIR

Manufacturer / Recalling Firm: Zydus Pharmaceuticals (USA) Inc
Reason for Recall: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
FDA Report: Oct 08, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.
Lots / Batch Codes & Expiration Dates
Lot#: E409309, Exp 12/31/2026
Distribution Scope
Distributed Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0676-2025

BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION

Manufacturer / Recalling Firm: Apotex Corp.
Reason for Recall: Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
FDA Report: Oct 08, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL).
Lots / Batch Codes & Expiration Dates
a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL) b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)
Distribution Scope
Nationwide in the US
Class II (Moderate Risk)
Drug recall Recall #: D-0001-2026

ENTECAVIR

Manufacturer / Recalling Firm: Zydus Pharmaceuticals (USA) Inc
Reason for Recall: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
FDA Report: Oct 08, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Lots / Batch Codes & Expiration Dates
Lot#: E409308, Exp 12/31/2026
Distribution Scope
Distributed Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0659-2025

Quick Touch Alcohol Prep Pads

Manufacturer / Recalling Firm: YANGZHOU YULOU PAPER PRODUCTS CO., LTD
Reason for Recall: cGMP Deviations
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per carton, AUM Pharmaceuticals, 320 Oser Ave., Hauppauge, NY 11788.
Lots / Batch Codes & Expiration Dates
Lot #: 20240610, Exp. Date 06/2029
Distribution Scope
N/A
Class III (Low Risk)
Drug recall Recall #: D-0673-2025

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Manufacturer / Recalling Firm: Granules Pharmaceuticals Inc.
Reason for Recall: Failed Impurities/Degradation Specifications:
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01
Lots / Batch Codes & Expiration Dates
Lot#: GPC250181A, Exp Date: 06-19-2027
Distribution Scope
Distributed Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0665-2025

Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10%

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10% (Benzoyl Peroxide 10%) 7oz (201 g), Torreypines.com
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class II (Moderate Risk)
Drug recall Recall #: D-0664-2025

Skin MD by Dr Monika Kiripolsky

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Skin MD by Dr Monika Kiripolsky, Body Acne Cleanser (Benzoyl Peroxide 10%), 7 oz (201 g), Monika Kiripolsky, MD Beverly Hills, CA, 90211
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class III (Low Risk)
Drug recall Recall #: D-0674-2025

POVIDONE-IODINE

Manufacturer / Recalling Firm: Medline Industries, LP
Reason for Recall: Subpotent drug
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
READYPREP PVP, Povidone-Iodine 10% Solution, Topical Antiseptic, Not Sterile, 1 Gallon (3.78 L) per bottle, Manufactured in USA by Medline Industries, LP., Three Lakes Drive, Northfield, IL 60093, NDC 53329-939-25
Lots / Batch Codes & Expiration Dates
Lot # 24EJA180, Exp 06/01/2027
Distribution Scope
Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0667-2025

Micronized BPO Gel Cleanser 10%

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 oz (201 g), University Skin Institute, 650 University Ave, Ste 200, Sacramento, CA 95825.
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class III (Low Risk)
Drug recall Recall #: D-0671-2025

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Manufacturer / Recalling Firm: Granules Pharmaceuticals Inc.
Reason for Recall: Failed Impurities/Degradation Specifications:
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01
Lots / Batch Codes & Expiration Dates
Lot#: GPC250178A, Exp Date: 06-22-2027
Distribution Scope
Distributed Nationwide in the USA
Class III (Low Risk)
Drug recall Recall #: D-0669-2025

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Manufacturer / Recalling Firm: Granules Pharmaceuticals Inc.
Reason for Recall: Failed Impurities/Degradation Specifications:
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01
Lots / Batch Codes & Expiration Dates
Lot#: GPC250158A, Exp Date: 06-22-2027
Distribution Scope
Distributed Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0666-2025

mel rx Skin

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class III (Low Risk)
Drug recall Recall #: D-0670-2025

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Manufacturer / Recalling Firm: Granules Pharmaceuticals Inc.
Reason for Recall: Failed Impurities/Degradation Specifications:
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01
Lots / Batch Codes & Expiration Dates
lot#: GPC250159A, Exp Date: 06-22-2027
Distribution Scope
Distributed Nationwide in the USA
Class III (Low Risk)
Drug recall Recall #: D-0672-2025

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Manufacturer / Recalling Firm: Granules Pharmaceuticals Inc.
Reason for Recall: Failed Impurities/Degradation Specifications:
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01
Lots / Batch Codes & Expiration Dates
Lot#: GPC250179A, Exp Date: 06-22-2027
Distribution Scope
Distributed Nationwide in the USA
Class II (Moderate Risk)
Drug recall Recall #: D-0663-2025

ARTISAN OF SKIN

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of Skin Beverly Hills, CA 90210
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class III (Low Risk)
Drug recall Recall #: D-0660-2025

70% ISOPROPYL RUBBING ALCOHOL

Manufacturer / Recalling Firm: Consumer Product Partners, LLC
Reason for Recall: Cross Contamination with Other Products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Kroger 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 30142-810-14
Lots / Batch Codes & Expiration Dates
Lot 0662036; Exp. Date 06/19/2027
Distribution Scope
US Nationwide.
Class III (Low Risk)
Drug recall Recall #: D-0661-2025

70% ISOPROPYL RUBBING ALCOHOL

Manufacturer / Recalling Firm: Consumer Product Partners, LLC
Reason for Recall: Cross Contamination with Other Products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
TopCare Health 70% Isopropyl Alcohol, NET WT 5.5 OZ (156 g) per can, Distributed By The KROGER CO., Cincinnati, Ohio 45202. NDC: 36800-589-14
Lots / Batch Codes & Expiration Dates
Lot 0662036; Exp Date 06/19/2027
Distribution Scope
US Nationwide.
Class II (Moderate Risk)
Drug recall Recall #: D-0668-2025

edunn clarity

Manufacturer / Recalling Firm: Private Label Skin Care Inc.
Reason for Recall: Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 oz (201g) Uptown Medi Spa, Phoenix, AZ.
Lots / Batch Codes & Expiration Dates
Lot # 58170A and 58172A, Exp Date: 09/2025
Distribution Scope
CA, GA only
Class II (Moderate Risk)
Drug recall Recall #: D-0662-2025

AZELAIC ACID

Manufacturer / Recalling Firm: Glenmark Pharmaceuticals Inc., USA
Reason for Recall: CGMP Deviations: Market complaints received for gritty texture (grainy)
FDA Report: Oct 01, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52
Lots / Batch Codes & Expiration Dates
Batch # 19252524, Exp Date: May 2027
Distribution Scope
Nationwide within the United States
Class II (Moderate Risk)
Drug recall Recall #: D-0654-2025

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Manufacturer / Recalling Firm: Northwind Pharmaceuticals LLC
Reason for Recall: Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was de...
FDA Report: Sep 24, 2025 Status: Ongoing Voluntary: Firm initiated Source: FDA
View Full Report
Affected Product Description
Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottles (NDC 51655-307-87), b) 10-count bottles (NDC 51655-307-53), c) 14-count bottles (NDC 51655-307-84), d) 20-count bottles (NDC 51655-307-20) Rx Only, Repackaged from Amneal Pharmaceuticals LLC. Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Lots / Batch Codes & Expiration Dates
Lot #: a) F118062503, Exp Date 05/31/2027, F118062507, Exp Date. 07/31/2027. b) F118062504, F118062505, Exp. Date 05/31/2027; F118062509, Exp. Date. 08/31/2027; F118062512, Exp. Date 04/30/2027. c) F118062506, Exp. Date 06/30/2027. d) F118062423, Exp. Date 01/31/2027; F118062501, Exp. Date 06/30/2027; F118062502, Exp. Date 04/30/2027; F118062508, E...
Distribution Scope
Nationwide within the United States

FDA Recall Classes & Health Hazard Definitions

Official regulatory classifications defined by the U.S. Food & Drug Administration (21 CFR Part 7)

FDA Health Hazard Classifications
Class I — High Risk Severity

Class I Recall

Regulatory Definition: A situation in which there is a reasonable probability that exposure to a recalled product will cause serious adverse health consequences or death.

Examples: Microbial contamination of sterile injectables, presence of unlabelled severe allergens, toxic impurities, or dosage potency errors.
Class II — Moderate Risk Severity

Class II Recall

Regulatory Definition: A situation in which exposure to a recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse consequences is remote.

Examples: Sub-potent non-life-sustaining tablets, minor dissolution rate variations, or outer carton label misprints.
Class III — Low Risk Severity

Class III Recall

Regulatory Definition: A situation in which exposure to a recalled product is not likely to cause adverse health consequences, but violates FDA packaging or manufacturing regulations.

Examples: Minor packaging flaws, harmless tablet color variances, or minor typographical errors in package inserts.
Enforcement Action Statuses
Ongoing Action

Ongoing Status

The recall action is actively in progress across supply chains, distributors, healthcare facilities, and retail pharmacies nationwide.

Completed / Terminated

Completed & Terminated Status

The FDA has confirmed that all reasonable efforts have been made to remove or correct the product, and the enforcement file is officially closed.

System Notice

Confirm Action